$KOPN

KOPIN CORP

No enriched coverage for $KOPN in the last 7 days.

No SEC Form 4 filings for $KOPN in the last 30 days.

See all $KOPN insider activity →
Med

Kopin Corporation Q2 2026 Earnings: Revenue Beats $12.7 Million

Kopin (NASDAQ: KOPN) reported Q2 2026 revenue of $12.7 million, up 51% year over year, beating the $11.75 million consensus forecast. EPS was $0.00 versus a $0.03 loss a year earlier, with net income of $0.9 million. Management said it expects GAAP profitability and positive free cash flow in Q4 2026; shares rose 9.12% after hours.

Kopin Corporation Q2 2026 Earnings Call Summary

Kopin Corporation reported Q2 2026 progress on U.S. Army color microLED and Pentagon Drone Dominance Program FPV drone prototypes, and said it is developing AI infrastructure Neural I/O optical transceivers. Management expects GAAP profitability and positive free cash flow in Q4 2026, microLED domestic production mid-2027, and a 1.6 Tbps CES 2027 demo. It cited a $1.4M Kopin Europe deconsolidation loss and a $2.1M tax benefit.

Today’s top U.S. stock movers: Fermi, NIQ and others surge on AI and biotech catalysts

Investing.com reports major U.S. stock movers, led by FRMI up 22.2% on an AI campus lease and potential revenue expansion, ALMR up 28.3% after launching an immune profiling panel, and Hertz up 24.5% on index removal and heavy options activity. Other gainers include Septerna, Rapid7, Kopin, and NextNav, with catalysts tied to AI, biotech, and earnings.

KOPN sentiment & insider activity

Recent KOPN coverage spans earnings, market movers and technology.

What's driving KOPN

  • The earnings beat plus managements Q4 2026 profitability and FCF expectation is a near-term catalyst, but operating loss and negative operating cash flow temper conviction.

    sci-tech-today.com · Aug 14, 2026

  • Management’s profitability and manufacturing timeline guidance is a direct catalyst for valuation and risk premium on KOPN.

    yahoo.com · Aug 13, 2026

  • Speculation-driven move; insider activity can be mixed and needs context (buy vs sell).

    investing.com · Aug 11, 2026

  • The stock move is framed as a catalyst-driven rerating tied to MicroLED development progress.

    yahoo.com · Aug 11, 2026

  • Earnings beat plus a clear profitability timeline and a same-day AI optical interconnect milestone are likely to sustain momentum and re-rate near-term expectations.

    investing.com · Aug 11, 2026

alphai scores every news story that mentions KOPN with an AI model for sentiment and relevance, and aggregates insider trades from KOPIN CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KOPN

Score
$KOPNMedAI 8/10

Kopin Corporation Q2 2026 Earnings: Revenue Beats $12.7 Million

Kopin (NASDAQ: KOPN) reported Q2 2026 revenue of $12.7 million, up 51% year over year, beating the $11.75 million consensus forecast. EPS was $0.00 versus a $0.03 loss a year earlier, with net income of $0.9 million. Management said it expects GAAP profitability and positive free cash flow in Q4 2026; shares rose 9.12% after hours.

$KOPNMed

Kopin Corporation Q2 2026 Earnings Call Summary

Kopin Corporation reported Q2 2026 progress on U.S. Army color microLED and Pentagon Drone Dominance Program FPV drone prototypes, and said it is developing AI infrastructure Neural I/O optical transceivers. Management expects GAAP profitability and positive free cash flow in Q4 2026, microLED domestic production mid-2027, and a 1.6 Tbps CES 2027 demo. It cited a $1.4M Kopin Europe deconsolidation loss and a $2.1M tax benefit.

$KOPNMed

Kopin Soars Tuesday Following MicroLED Development Award

Kopin shares rose after a MicroLED development award, with analysts citing supportive coverage. Wall Street’s average price target is $7.62 (six Buy, no Holds or Sells). GuruFocus flagged the stock as 308.7% overvalued. The move also lifted microdisplay and defense peers including Vuzix, Himax, Universal Display, and AeroVironment.

$KOPNHighAI 9/10

Why is Kopin stock surging today?

Kopin Corp (KOPN) shares rose about 26% after the company reported Q2 2026 results above expectations, with revenue of $12.7M versus $11.75M consensus and net income of $0.9M versus a $5.2M loss a year earlier. Kopin also guided to full GAAP profitability by Q4 2026 and said its Neural I/o MicroLED optical interconnect with Fabric.AI remains on track for a CES 2027 demo.

$KOPNMed

KOPIN CORP (KOPN): Results of Operations and Financial Condition

KOPIN CORP (KOPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Kopin Corporation Reports Second Quarter 2026 Financial Results Three Major Milestones Achieved in U.S. Army Color MicroLED Program, Including Record-Setting 150,000+ Nit Full-Color Brightness and Installation of U.S. Bonding Capability, Keeping Kopin on Track for Do

$KOPNLow

Why Kopin Corporation (KOPN) is One of the Best Strong Buy Penny Stocks to Invest in Now

Kopin Corp (NASDAQ:KOPN) said June 29 it received multiple new orders from customers evaluating its Sentinel First Person Viewer for the US Government’s one-way attack drone initiative. It said some customers are contenders in the Drone Dominance Program. On June 23, Kopin announced plans to open a Dallas Optics and Photonics Design Center to expand US engineering and speed Neural I/O development.

2026 - 06 - 23 | Kopin Expands U.S. Operations With New Optics & Photonics Design Center in Dallas, Texas | NDAQ: KOPN

Kopin (NASDAQ: KOPN) plans to open a new Optics and Photonics Design Center in Dallas, Texas, before end-2026. The site will expand U.S. engineering and small-scale manufacturing for next-generation optical interconnects, co-packaged optics, and its Neural I/O™ technology for AI data centers. The center will include optics labs, R&D, and Neural I/O™/ASOS manufacturing capacity.

$KOPNMedAI 9/10

Kopin (NASDAQ:KOPN) Stock Price Down 8.4% – Time to Sell?

Kopin (NASDAQ:KOPN) shares fell 8.4% on Friday to about $5.54, after trading as low as $5.56; volume was 1.79M shares versus a 5.51M average. The company reported Q1 EPS of -$0.02 (vs -$0.01 consensus) on revenue of $10.55M (vs $9.96M). Analysts cited mixed ratings, with a consensus target of $7.15.

$KOPNMed

DNB Asset Management AS Has $3.03 Million Stake in Kopin Corporation $KOPN

DNB Asset Management AS significantly increased its stake in Kopin Corporation by 123.2% in the fourth quarter, now holding 1,294,368 shares valued at approximately $3.03 million. Despite recent insider selling by Kopin's CEO and COO, analysts generally maintain a "Moderate Buy" rating with a consensus price target of $7.15. The company recently reported a quarterly EPS loss of ($0.02), slightly below expectations, on revenue of $10.55 billion.

Related tickers